Statistics

Total Visits

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer101

Select a period of time:

Number of views in the range

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer28

Views

Views
November 20257
December 20251
January 202611
February 20260
March 20266
April 20261
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Argentina3
Colombia2
Brazil2
Australia1
Chile1
Finland1
Hungary1
Ireland1
Paraguay1
 

Top cities views

Views
San Jose8
Asunción1
Bucaramanga1
Burzaco1
Cúcuta1
Dublin1
Helsinki1
Istanbul1
Ituzaingó1
La Francia1